Hony offloads 11% stake in CSPC

The private equity firm raises HK$4.095 billion from the sale of 650 million secondary shares in the Chinese pharmaceuticals group.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES